IRS1 and multiple system atrophy: When high doses of exendin-4 were administered in vivo in mice, a mitigation of MSA symptoms and signs was observed in terms of motor performance amelioration, reduced load of cytoplasmic aggregates, and restoration of IRS1 phosphorylation levels in plasma neural cells (71).